SAMANTHA DE LA GARZA: Open Payments
NPI 1033802665 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,618 in 29 payments from 9 companies in 2025. Trend: 2023 $282 · 2024 $366 · 2025 $1,618
Food & beverage: $859Travel & lodging: $760
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 15 | $1,256 |
| CVRx, Inc. | 1 | $149 |
| Boston Scientific Corporation | 4 | $66 |
| PFIZER INC. | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Medtronic, Inc. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Amgen Inc. | 1 | $14 |
Products named: CARDIOMEMS, Barostim Neo System, CDS - MCT/CEM Monitoring, ELIQUIS, JARDIANCE, LINQ II, CAMZYOS, LOKELMA.
Industry payments across TX — which companies pay providers there.
